Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A team of experts at the Pandemic Sciences Institute at the University of Oxford and Department of Statistics at the University of Warwick estimate the NHS COVID-19 app prevented around 1 million cases, 44,000 hospitalisations and 9,600 deaths during its first year.

A person holds a mobile phone displaying the NHS COVID-19 app

The new research, published today (22 February 2023) in Nature Communications, is the most comprehensive evaluation of the NHS COVID-19 contact tracing app to date. 

Researchers analysed the NHS COVID-19 app in England and Wales in the first year of its use – September 2020 to September 2021. They found that the app played an important role in reducing transmission of COVID-19 in England and Wales. The app experienced high user engagement, identified infectious contacts well, and helped to prevent significant numbers of cases, hospitalisations and deaths.

Professor Christophe Fraser, Principle Investigator at the Pandemic Sciences Institute at the University of Oxford’s Nuffield Department of Medicine and the paper’s senior author said, “Many of us will remember being ‘pinged’ by the NHS COVID-19 app at the height of the pandemic, and the impact that self-isolating had on our daily lives.

Our research shows that the NHS COVID-19 app worked, and it worked well. Through our analysis we estimate the app saved almost 10,000 lives in its first year alone.

The app prevented people transmitting the virus by generating notifications that they had been exposed to confirmed cases. The app’s effectiveness improved over time, particularly as rapid testing became more widely adopted, reducing the need for people to self-isolate following a ‘ping’.

We find that digital contact tracing, a relatively low-cost and rapidly available intervention is a valuable public health measure for reducing transmission in any future epidemic waves of COVID-19 or similar viruses.”

Read the full story on the NDM Pandemic Sciences Institute. 

Similar stories

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.

Showcasing Oxford’s translational research for Rare Disease Day

Rare Disease Day is an annual awareness day that aims to educate and raise awareness for the 400 million people worldwide who live with a rare disease.

Prostate cancer AI diagnosis tool begins evaluation in Oxford

New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.